A

Amneal Intermediate Inc
NASDAQ:AMRX

Watchlist Manager
Amneal Intermediate Inc
NASDAQ:AMRX
Watchlist
Price: 12.21 USD -0.33% Market Closed
Market Cap: 3.8B USD

Net Margin
Amneal Intermediate Inc

0.2%
Current
-3%
Average
4.6%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
0.2%
=
Net Income
5.9m
/
Revenue
2.9B

Net Margin Across Competitors

No Stocks Found

Amneal Intermediate Inc
Glance View

Market Cap
3.8B USD
Industry
Pharmaceuticals

Amneal Intermediate Inc. operates as a vital player within the pharmaceutical industry, bringing a unique blend of agility and scale to its business operations. Formed from the merger of Amneal Pharmaceuticals LLC and Impax Laboratories, the company has established a broad footprint in both generic and specialty pharmaceuticals. Amneal leverages its extensive manufacturing capabilities to produce a diverse portfolio of generic medications, which is not only cost-effective for patients but also represents a significant revenue stream. Its strategic approach lies in launching high-barrier-to-entry generics, ensuring that the products have minimal competition in the market. This strategy not only helps in capturing market share swiftly but also supports better pricing power. Alongside its robust generics division, Amneal invests substantially in its specialty segment. This arm of the company focuses on developing branded pharmaceuticals, particularly in therapeutic areas such as central nervous system disorders, endocrinology, and oncology. By placing strategic bets on these high-growth areas, Amneal aims to capture another layer of the lucrative pharmaceutical market. Its knack for identifying unmet medical needs and bringing timely, effective treatments to market highlights the company's commitment to innovation and patient care. Together, the combination of high-volume generic production and targeted specialty drug development creates a well-rounded business model designed to drive sustainable growth in a competitive industry.

AMRX Intrinsic Value
HIDDEN
Show
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
0.2%
=
Net Income
5.9m
/
Revenue
2.9B
What is the Net Margin of Amneal Intermediate Inc?

Based on Amneal Intermediate Inc's most recent financial statements, the company has Net Margin of 0.2%.

Back to Top